Citigroup Inc Inovio Pharmaceuticals, Inc. Transaction History

Citigroup Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$0.35 - $0.53 $1,165 - $1,764	-3,329 Reduced 96.8%	110 $0
Q3 2023 Nov 09, 2023	SELL	$0.38 - $0.58 $540 - $825	-1,423 Reduced 29.27%	3,439 $1,000
Q2 2023 Aug 10, 2023	SELL	$0.39 - $0.94 $723,499 - $1.74 Million	-1,855,127 Reduced 99.74%	4,862 $2,000
Q1 2023 May 11, 2023	BUY	$0.79 - $1.91 $537,167 - $1.3 Million	679,959 Added 57.62%	1,859,989 $1.53 Million
Q4 2022 Feb 09, 2023	SELL	$1.41 - $2.5 $1.18 Million - $2.09 Million	-834,269 Reduced 41.42%	1,180,030 $1.84 Million
Q3 2022 Nov 10, 2022	BUY	$1.66 - $2.79 $787,596 - $1.32 Million	474,456 Added 30.81%	2,014,299 $3.48 Million
Q2 2022 Aug 10, 2022	BUY	$1.44 - $3.98 $1.76 Million - $4.87 Million	1,223,351 Added 386.53%	1,539,843 $2.66 Million
Q1 2022 May 12, 2022	SELL	$2.97 - $5.2 $1.34 Million - $2.34 Million	-450,233 Reduced 58.72%	316,492 $1.14 Million
Q4 2021 Feb 10, 2022	BUY	$4.99 - $7.46 $1.97 Million - $2.94 Million	394,407 Added 105.93%	766,725 $3.83 Million
Q3 2021 Nov 10, 2021	BUY	$7.16 - $9.69 $2.67 Million - $3.61 Million	372,318 New	372,318 $2.67 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $476M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.